|
Hydrochlorothiazide W/ ReserpineDrug - Hydrochlorothiazide W/ Reserpine The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydrochlorothiazide; Reserpine
Strength -
50MG;0.125MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
084467
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Hydrochlorothiazide W/ Reserpine
Hydrochlorothiazide W/ Reserpine 50mg;0.125mg Tablet; Oral
Hydrochlorothiazide W/ Reserpine 50mg;0.1mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 25mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 50mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 50mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 25mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 25mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 25mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 50mg;0.125mg Tablet; Oral Hydrochlorothiazide W/ Reserpine 50mg;0.125mg Tablet; Oral NewDrugInformation |